IL17A and Parkinson disease: It has been shown that in patients with Parkinson's disease, IL-6 correlates positively with motor symptoms severity, while IL-17 correlates with non-motor symptoms, specifically mood and cognition scores, with a negative correlation reported between IL-17 and cognitive deterioration (46).